These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19753470)

  • 1. Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification.
    Rassi A; Rassi A; Marin-Neto JA
    Mem Inst Oswaldo Cruz; 2009 Jul; 104 Suppl 1():152-8. PubMed ID: 19753470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of chronic Chagas heart disease.
    Marin-Neto JA; Cunha-Neto E; Maciel BC; Simões MV
    Circulation; 2007 Mar; 115(9):1109-23. PubMed ID: 17339569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chagasic myocardiopathy: historical perspective].
    Elizari MV
    Medicina (B Aires); 1999; 59 Suppl 2():25-40. PubMed ID: 10668240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chagas cardiomyopathy--where do we stand after a hundred years?
    Biolo A; Ribeiro AL; Clausell N
    Prog Cardiovasc Dis; 2010; 52(4):300-16. PubMed ID: 20109600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality prediction in Chagas heart disease.
    Nunes MC; Carmo AA; Rocha MO; Ribeiro AL
    Expert Rev Cardiovasc Ther; 2012 Sep; 10(9):1173-84. PubMed ID: 23098153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of chronic Chagas' heart disease: prognosis factors.
    Mady C; Nacruth R
    Sao Paulo Med J; 1995; 113(2):791-6. PubMed ID: 8650478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and management of Chagas disease and cardiomyopathy.
    Ribeiro AL; Nunes MP; Teixeira MM; Rocha MO
    Nat Rev Cardiol; 2012 Oct; 9(10):576-89. PubMed ID: 22847166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of cross-reactive host-pathogen antibodies in patients with different stages of chronic Chagas disease.
    Vicco MH; Ferini F; Rodeles L; Cardona P; Bontempi I; Lioi S; Beloscar J; Nara T; Marcipar I; Bottasso OA
    Rev Esp Cardiol (Engl Ed); 2013 Oct; 66(10):791-6. PubMed ID: 24773859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chagas Cardiomyopathy and Myocardial Sympathetic Denervation.
    Gadioli LP; Schmidt A; Maciel BC; Volpe GJ; Simões MV; Marin-Neto JA
    Curr Cardiol Rep; 2024 Jun; 26(6):635-641. PubMed ID: 38656586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chagas disease as a cause of heart failure and ventricular arrhythmias in patients long removed from endemic areas: an emerging problem in Europe.
    Vannucchi V; Tomberli B; Zammarchi L; Fornaro A; Castelli G; Pieralli F; Berni A; Yacoub S; Bartoloni A; Olivotto I
    J Cardiovasc Med (Hagerstown); 2015 Dec; 16(12):817-23. PubMed ID: 25022923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk stratification in Chagas disease].
    Barbosa MM; Nunes MC
    Rev Esp Cardiol (Engl Ed); 2012 Jul; 65 Suppl 2():17-21. PubMed ID: 22921170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arrhythmias in chagasic cardiomyopathy.
    Healy C; Viles-Gonzalez JF; Sáenz LC; Soto M; Ramírez JD; d'Avila A
    Card Electrophysiol Clin; 2015 Jun; 7(2):251-68. PubMed ID: 26002390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic Chagas Heart Disease Management: From Etiology to Cardiomyopathy Treatment.
    Bocchi EA; Bestetti RB; Scanavacca MI; Cunha Neto E; Issa VS
    J Am Coll Cardiol; 2017 Sep; 70(12):1510-1524. PubMed ID: 28911515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIF-1α and CD73 expression in cardiac leukocytes correlates with the severity of myocarditis in end-stage Chagas disease patients.
    Eberhardt N; Sanmarco LM; Bergero G; Favaloro RR; Vigliano C; Aoki MP
    J Leukoc Biol; 2021 Jan; 109(1):233-244. PubMed ID: 32450615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stroke in Chagas disease: from pathophysiology to clinical practice.
    Lage TAR; Tupinambás JT; Pádua LB; Ferreira MO; Ferreira AC; Teixeira AL; Nunes MCP
    Rev Soc Bras Med Trop; 2022; 55():e0575. PubMed ID: 35674560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanical Dispersion Assessed by Strain Echocardiography Is Associated with Malignant Arrhythmias in Chagas Cardiomyopathy.
    Barros MV; Leren IS; Edvardsen T; Haugaa KH; Carmo AA; Lage TA; Nunes MC; Rocha MO; Ribeiro AL
    J Am Soc Echocardiogr; 2016 Apr; 29(4):368-74. PubMed ID: 26833338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations.
    Garcia S; Ramos CO; Senra JF; Vilas-Boas F; Rodrigues MM; Campos-de-Carvalho AC; Ribeiro-Dos-Santos R; Soares MB
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1521-8. PubMed ID: 15793134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parasitaemia and parasitic load are limited targets of the aetiological treatment to control the progression of cardiac fibrosis and chronic cardiomyopathy in Trypanosoma cruzi-infected dogs.
    Caldas IS; Menezes APJ; Diniz LF; Nascimento ÁFDSD; Novaes RD; Caldas S; Bahia MT
    Acta Trop; 2019 Jan; 189():30-38. PubMed ID: 30290285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A modified and unifying neurogenic hypothesis can explain the natural history of chronic Chagas heart disease.
    Dávila DF; Donis JH; Torres A; Ferrer JA
    Int J Cardiol; 2004 Aug; 96(2):191-5. PubMed ID: 15262032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autonomic neuroimmunomodulation in chagasic cardiomyopathy.
    Ribeiro Machado MP; Dias da Silva VJ
    Exp Physiol; 2012 Nov; 97(11):1151-60. PubMed ID: 22581749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.